Placebo Controlled Trial of Dextromethorphan in Rett Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

October 26, 2016

Study Completion Date

October 26, 2016

Conditions
Rett Syndrome
Interventions
DRUG

dextromethorphan

The DM group will take 5mg/kg/day orally in 2 divided doses 12 hours apart for the 3 month period of the study. The pharmacists will dispense the DM to the study participants.

DRUG

placebo

The placebo will be dispensed to equal the volume of DM of 5mg/kg/day. It is taken orally in 2 divided doses 12 hours apart during the study period of 3 months. The Research pharmacist will dispense the placebo to the participants.

Trial Locations (1)

21287

The Johns Hopkins Institute for Clinical and Translational Research, Baltimore

All Listed Sponsors
collaborator

The Johns Hopkins Institute for Clinical and Translational Research (ICTR)

UNKNOWN

lead

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

OTHER

NCT01520363 - Placebo Controlled Trial of Dextromethorphan in Rett Syndrome | Biotech Hunter | Biotech Hunter